Your session is about to expire
← Back to Search
Evidence-Based Practices for High-Risk Veteran Care (RIVET Trial)
RIVET Trial Summary
This trial will test different approaches to increase use of evidence-based practices for high-risk Veterans in primary care, provide rapid data feedback to VHA on high-risk patient care, build capacity for the implementation of evidence-based practices, and train future leaders in high-risk Veteran care.
RIVET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RIVET Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: HCMA-EBQI-IC
- Group 2: HCMA-EBQI-LC
- Group 3: CACP-EBQI-IC
- Group 4: CACP-EBQI-LC
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide an estimation of how many people are eligible for entry into this experiment?
"Correct. According to the records on clinicaltrials.gov, recruitment for this medical trial is currently underway, having first been posted on July 23rd 2021 and most recently updated on August 30th 2022. This project seeks 14 volunteers at 1 designated site of research."
Is it possible to participate in this experimentation presently?
"This medical study, which was initially posted on July 23rd 2021 is currently accepting patients. The trial's details were recently revised on August 30th 2022 according to clinicaltrials.gov."
Share this study with friends
Copy Link
Messenger